Publication
Lesion detection by [Zr-89]Zr-DFO-girentuximab and [F-18] FDG-PET in patients with newly diagnosed metastatic renal cell carcinoma
Verhoeff, S., van Es, S. C., Boon, E., van Helden, E., Angus, L., Elias, S. G., Oosting, S. F., Aarntzen, E. H., Brouwers, A. H., Kwee, T. C., Heskamp, S., Hoekstra, O. S., Verheul, H., Zwezerijnen, G. J. C., van Oordt, C. M. D. H., van der Veldt, A. A. M., de Vries, E. G. E., Boerman, O. C., van der Graaf, W. T. A., Oyen, W. J. G. & van Herpen, C. M. L., Oct-2019, In : European Journal of Nuclear Medicine and Molecular Imaging. 46, SUPPL 1, p. S67 1 p.Research output: Contribution to journal › Meeting Abstract › Academic
| Original language | English |
|---|---|
| Pages (from-to) | S67 |
| Number of pages | 1 |
| Journal | European Journal of Nuclear Medicine and Molecular Imaging |
| Volume | 46 |
| Issue number | SUPPL 1 |
| Publication status | Published - Oct-2019 |
| Event | 32nd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) - Barcelona, Spain Duration: 12-Oct-2019 → 16-Oct-2019 |
Event
32nd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)
12/10/2019 → 16/10/2019
Barcelona, SpainEvent: Conference
ID: 107803289